SUMMARY Patients with ataxia telangiectasia (AT) syndrome exhibit a high level of spontaneous chromosome aberrations, with hypersensitivity to gamma radiation and radiomimetic chemicals at the chromosomal and cellular level.
Pregnancies at risk for AT have been monitored by screening second trimester amniotic fluid (AF) samples for chromosome instability and biochemical abnormalities.12-15 At least two fetuses have been diagnosed as affected, and the pregnancies terminated. 13 15 The parents of affected patients run a 25% risk of recurrence in any future pregnancy, and they would benefit greatly if first trimester prenatal diagnosis became available, as early termination of an affected pregnancy would then be possible. Chorionic villus sampling (CVS) is an alternative procedure for the prenatal diagnosis of chromosome abnormalities and can be performed in the early stages of pregnancy. 16 17 Fetuses at risk for Fanconi's anaemia, another chromosome instability disorder, have already been screened successfully in the first trimester of pregnancy using direct,'8 semidirect, '9 and culture' 20 preparations from chorion biopsies.
In this report we describe the first cytogenetic approach to the prenatal diagnosis of AT using CVS. The level of spontaneous and induced 174 chromosome abnormalities was established in direct, semidirect, and culture preparations from normal CVS samples which had been exposed to gamma radiation and bleomycin (BLM) treatments. Data from these studies were then used to screen a first trimester pregnancy at risk for AT syndrome, and CVS results were eventually confirmed by analysis of amniotic fluid and lymphocyte cultures. 
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